Skip to main content

CV Sciences, Inc.

corporate_fare Company Profile

CV Sciences, Inc.

CVSI·OTC·Life Sciences·CIK 0001510964

CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The company sells its hemp extracts and other natural ingredients and products through both business-to-business (B2B) and business-to-consumer (B2C) channels. Its +PlusCBD™ branded products are sold at select retail locations across the U.S. and are the top-selling brands of hemp extracts in the natural products market, according to SPINS. +PlusCBD™ product benefits in healthy people are supported by human clinical research data and three published clinical case studies on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to achieve self-affirmed Generally Recognized as Safe (GRAS) status. On December 7, 2023, CV Sciences acquired Cultured Foods Sp. z.o.o., a leading European manufacturer and distributor of plant-based protein products, making it a wholly owned subsidiary. In January 2025, the company launched Lunar Fox™, a brand focused on distributing plant-based products in the U.S. market. The Cultured Foods™ and Lunar Fox™ brands offer a variety of 100% plant-based food products. In May 2024, CV Sciences acquired Elevated Softgels, LLC, a Colorado-based manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. In August 2024, the company engaged Maxim Group, LLC as a non-exclusive financial advisor and investment banker.

CV Sciences, Inc. (OTC:CVSI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for CVSI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-26, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for CVSI spans 8-K, 4, 10-Q, DEF 14A.

Recent high-impact activity:

  • CV Sciences Settles Former Counsel Arbitration, Receives $500,000 Cash
  • 10% Owner Charles Cheever Buys $114.8K of CVSI Stock at $0.02
  • CV Sciences Q2 Revenue Drops 17.5%, Going Concern Warning Reiterated
  • Shareholders Reject Reverse Stock Split Proposal Amidst Going Concern Warning
  • Q1 Revenue Drops 11.4%, Net Loss Widens Amid Going Concern & Major Dilution

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$13.79M
Net Income
-$958K
Diluted EPS
-$0.01
Op. Cash Flow
-$407K
Free Cash Flow
-$516K
Gross Profit
$6.75M
Operating Income
-$470K
Cash & Equivalents
$278K
Total Debt
$1.65M
Debt / Equity
1.12×
Net Margin
-6.9%
Shares Outstanding
184.26M sh
Source: 10-K · filed 2026-03-26 · accession 0001193125-26-126598

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 36,668 shares in CVSI as of the October 15, 2026 settlement, a 158.4% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 29, 2026, 70.3% of CVSI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)36,668 shares as of October 15, 2026
Change vs prior period▲ 158.4%
Days to cover1.00 at avg daily volume of 349,897
Daily short volume (FINRA facilities)70.3% of 125,518 shares on October 29, 2026
5-day average short volume66.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$0.0085 +2.41% today
52-week range · as of 2026-10-26 $0.0085 – $0.10
Market cap
$1.92M
Volume
125.5K (0.3× avg)
3-mo avg 450.8K
Live data · 2026-10-30 01:07 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed CVSI - Latest Insights

CVSI
Oct 26, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0105
Real-time Price: $0.0085 info
Change: -$0.0020 (-19%) info
Market Cap: $1.92M info
CVSI
Sep 09, 2026, 6:43 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.01898
Real-time Price: $0.0085 info
Change: -$0.01048 (-55%) info
Market Cap: $1.92M info
CVSI
Aug 13, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.02535
Real-time Price: $0.0085 info
Change: -$0.01685 (-66%) info
Market Cap: $1.92M info
CVSI
Jun 04, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.02914
Real-time Price: $0.0085 info
Change: -$0.02064 (-71%) info
Market Cap: $1.92M info
CVSI
May 15, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0301
Real-time Price: $0.0085 info
Change: -$0.0216 (-72%) info
Market Cap: $1.92M info
CVSI
May 14, 2026, 4:08 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.03075
Real-time Price: $0.0085 info
Change: -$0.02225 (-72%) info
Market Cap: $1.92M info
CVSI
May 14, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.03075
Real-time Price: $0.0085 info
Change: -$0.02225 (-72%) info
Market Cap: $1.92M info
CVSI
Apr 14, 2026, 9:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.03073
Real-time Price: $0.0085 info
Change: -$0.02223 (-72%) info
Market Cap: $1.92M info
CVSI
Apr 10, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.03609
Real-time Price: $0.0085 info
Change: -$0.02759 (-76%) info
Market Cap: $1.92M info
CVSI
Mar 26, 2026, 5:14 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.033
Real-time Price: $0.0085 info
Change: -$0.0245 (-74%) info
Market Cap: $1.92M info
CVSI
Mar 26, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.033
Real-time Price: $0.0085 info
Change: -$0.0245 (-74%) info
Market Cap: $1.92M info
CVSI
Mar 10, 2026, 5:16 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0456
Real-time Price: $0.0085 info
Change: -$0.0371 (-81%) info
Market Cap: $1.92M info
CVSI
Mar 10, 2026, 5:00 PM EDT
Source: Acceswire
Importance Score:
8
Price at Filing: $0.0456
Real-time Price: $0.0085 info
Change: -$0.0371 (-81%) info
Market Cap: $1.92M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets